Stockscreener 앱 받기
0.6706
5.74%
0.0364
시장 영업 전:
.67
-0.0006
-0.09%
Kala Bio Inc 주식(KALA)의 최신 뉴스
KALA BIO Inc (KALA) Institutional Confidence - TradingKey
KALA BIO Inc (KALA) Cash Flow - TradingKey
KALA BIO Inc (KALA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
KALA BIO Inc (KALA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
TradingKey - TradingKey
KALA|KALA BIO Inc|Price:0.634|Chg%:+0.024 - TradingKey
KALA Stock Hits Record Low – Firm Announces Reverse Split After Shares Fail To Surpass The $1 Mark - Stocktwits
KALA|KALA BIO Inc|Price:0.671|Chg%:+0.036 - TradingKey
KALA BIO, Inc. Revenue Breakdown – NASDAQ:KALA - TradingView
KALA BIO Inc (KALA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Kala Bio, Inc. Files Form 8-K with SEC Detailing Nasdaq Listing and Corporate Information - Minichart
KALA BIO Inc (KALA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Kala Bio Files ATM Offering Of Up To $250 Million In Common StockSEC Filing - TradingView
Frontier tech research, news & data - MLQ.ai
Kala Bio announces 1-for-50 reverse stock split effective Friday - Investing.com
Form 13D/A KALA BIO For: 2 July By Investing.com - Investing.com Nigeria
David Lazar trims KALA BIO (KALA) stake to 3.9% with 719,404 shares - Stock Titan
Price to earnings forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
KALA BIO Inc. (KALA) Holds Near Support After Slight Decline: Key Levels in FocusVanna Flow - dars.gov.et
[EFFECT] KALA BIO, Inc. SEC Filing - Stock Titan
Enterprise value to EBIT forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
Enterprise value to EBITDA forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
Price to book forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
Enterprise value to revenue forward of KALA BIO, Inc. – NASDAQ:KALA - TradingView
KALA BIO Surges on Heavy Volume: Biotech Stock Testing Key Resistance LevelsAAII Bearish - DonanımHaber
KALA BIO StockLong-term eye-disease strategy in focus - AD HOC NEWS
KALA BIO Inc (KALA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
KALA BIO Inc (KALA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
KALA BIO Inc (KALA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
KALA BIO Inc (KALA) Valuation: PE, PB & Fair Value Analysis - TradingKey
KALA BIO Inc. Surges 6.5% as Biotech Momentum Builds: Testing Key Resistance at $2.76Resistance Breakout Stocks - newsline.com
KALA Q4 2025 Earnings: Narrowed Loss Drives 6.5% Stock GainQuarterly Earnings Report - newsline.com
KALA BIO (NASDAQ: KALA) registers $350M shelf; 1-for-50 reverse split recorded - Stock Titan
KALA BIO Inc. (KALA) Holds Steady Near Support Amid Minimal Price MovementMoving Average Ribbon - newsline.com
KALA BIO (KALA) Holds Steady Near $2.39 Amid Tight Trading RangeUpthrust Pattern - newsline.com
KALA BIO Surges 11%: Approaching Key Resistance at $2.40Wave Truncation - newsline.com
KALA Q4 2025 Earnings: Narrower Loss Beats Expectations Amid Operational ProgressQuarterly Earnings - dars.gov.et
KALA BIO INC (KALA) Stock Chart - ChartMill
KALA Stock Price, Quote & Chart | KALA BIO INC (NASDAQ:KALA) - ChartMill
KALA BIO Q4 2025 Earnings: Wider-Than-Expected Loss but Narrower EPS Surprise Drives Mixed Sentiment - dars.gov.et
KALAKala Bio Inc Stock Price and Quote - Finviz
Net margin % of KALA BIO, Inc. – LSX:A4243T - TradingView
KALA BIO Shares Slide Over 6% Amid Light Trading and Sector PressureATR Stop - dars.gov.et
KALA BIO (KALA) Smashes Q4 2025 Views with $-33.50 EPSNegative Surprise Momentum - thelegaladvocate.com
KALA BIO (KALA) Q4 2025 Earnings Beat: Revenue $N/A, EPS $-33.50Free Cash Flow Trends - newsline.com
Kala Bio (FRA:27F) Cyclically Adjusted Price-to-FCF : (As of May. 17, 2026) - GuruFocus
Red Light Holland Corp (OP: TRUFF - FinancialContent
KALA stock hits record low – firm announces reverse split after shares fail to surpass the $1 mark - MSN
1.97%
0.83%
자본화:
|
볼륨(24시간):